References: |
deficiency. Clinical biochemistry. 23:537-542.
Bernardi, P., and V. Petronilli. 1996. The permeability transition pore as a mitochondrial calcium release channel: A critical appraisal. J Bioenerg Biomembr. 28:131-138.
Bindu, P.S., R. Christopher, A. Mahadevan, and R.D. Bharath. 2011. Clinical and imaging observations in isolated sulfite oxidase deficiency. J Child Neurol. 26:1036-1040.
Bor-Kucukatay, M., V. Kucukatay, A. Agar, and O.K. Baskurt. 2005. Effect of sulfite on red blood cell deformability ex vivo and in normal and sulfite oxidase-deficient rats in vivo. Archives of toxicology. 79:542-546.
Bridges, R.J., N.R. Natale, and S.A. Patel. 2012. System xc- cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS. British journal of pharmacology. 165:20-34.
Brorson, J.R., C.J. Marcuccilli, and R.J. Miller. 1995. Delayed antagonism of calpain reduces excitotoxicity in cultured neurons. Stroke; a journal of cerebral circulation. 26:1259-1266; discussion 1267.
Brown, G.C., and A. Bal-Price. 2003. Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Molecular neurobiology. 27:325-355.
Butler, M.H., A. Hayashi, N. Ohkoshi, C. Villmann, C.M. Becker, G. Feng, P. De Camilli, and M. Solimena. 2000. Autoimmunity to gephyrin in Stiff-Man syndrome. Neuron. 26:307-312.
Calabrese, V., C. Mancuso, M. Calvani, E. Rizzarelli, D.A. Butterfield, and A.M. Stella. 2007. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nature reviews. Neuroscience. 8:766-775.
Camins, A., E. Verdaguer, J. Folch, and M. Pallas. 2006. Involvement of calpain activation in neurodegenerative processes. CNS drug reviews. 12:135-148.
Cao, G., J. Xing, X. Xiao, A.K. Liou, Y. Gao, X.M. Yin, R.S. Clark, S.H. Graham, and J. Chen. 2007. Critical role of calpain I in mitochondrial release of apoptosis-inducing factor in ischemic neuronal injury. J Neurosci. 27:9278-9293.
Shimojima, K., M. Sugawara, M. Shichiji, S. Mukaida, R. Takayama, K. Imai, and T. Yamamoto. 2011. Loss-of-function mutation of collybistin is responsible for X-linked mental retardation associated with epilepsy. J Hum Genet. 56:561-565.
Touati, G., E. Rusthoven, E. Depondt, C. Dorche, M. Duran, B. Heron, D. Rabier, M. Russo, and J.M. Saudubray. 2000. Dietary therapy in two patients with a mild form of sulphite oxidase deficiency. Evidence for clinical and biological improvement. J Inherit Metab Dis. 23:45-53.
Touma, E., S. Kato, K. Fukui, and T. Koike. 2007. Calpain-mediated cleavage of collapsin response mediator protein(CRMP)-2 during neurite degeneration in mice. Eur J Neurosci. 26:3368-3381.
Tyagarajan, S.K., and J.M. Fritschy. 2014. Gephyrin: a master regulator of neuronal function? Nature reviews. Neuroscience. 15:141-156
Wenthold, R.J., R.S. Petralia, J. Blahos, II, and A.S. Niedzielski. 1996. Evidence for multiple AMPA receptor complexes in hippocampal CA1/CA2 neurons. J Neurosci. 16:1982-1989.
Witten, M.L., P.R. Sheppard, and B.L. Witten. 2012. Tungsten toxicity. Chemico-biological interactions. 196:87-88 |